Clinical Update

Reading Research: Details Matter

Topics: adverse events | control group | double blind | effect size | NNH | NNT | null hypothesis | number needed to harm | number needed to treat | Open Label | p-value | primary outcome | Randomized controlled trial | randomized discontinuation design | RCT | replication | secondary outcome | statistical significance | treatment efficacy | unblinded

When headlines report on positive treatment results from a study, families will come in asking about those results. This article will help you determine what makes a study a good one, and conversely what makes a not-so-great one. With this information, you can be better prepared to talk with families about research studies and results that can affect tr

Read More
Research Update

Vitamin B6 Lowers Prolactin on Antipsychotics

Topics: Antipsychotics | double blind | Prolactin | Randomized controlled trial | RCT | Schizophrenia | Vitamin B6

REVIEW OF: Zhuo C et al, Front Psychiatry 2021;12:681418 STUDY TYPE: Randomized, double-blind trial with an active control Hyperprolactinemia, a common problem on antipsychotics, can cause multiple issues, including sexual dysfunction and gynecomastia. It is a particular problem in treatment-resistant schizophrenia (TRS), as these patients often need

Read More